Search

everythinglearnresearchcommunity

for

Search:↓

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

PBMCsec can help reduce and improve thick skin scars.

Apremilast may help treat hair loss in alopecia areata.

The humanized AA mouse model is better for testing new alopecia areata treatments.

SM04755 may be an effective topical treatment for psoriasis.

scMC effectively separates biological signals from technical noise in single-cell genomics data.

Shift work disrupts the body's natural clock, leading to health problems.

A new mouse model helps understand and find treatments for alopecia areata.

Compounds 6f and 6g effectively stop prostate cancer cell growth without harming healthy cells.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

MNC-QQ cell therapy improved hair growth and quality of life in men with androgenic alopecia without adverse effects.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Xeno-free three-dimensional stem cell masses are safe and effective for improving blood flow and tissue repair in limb ischemia.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Some minoxidil combinations can help differentiate leukemia cells without harming other cells.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Transfected cells with VEGF and FGF2 genes improve skin wound healing by enhancing blood flow and regeneration.

Higher CRHR1 levels in AA patients lead to increased inflammation.